U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359248) titled 'Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache' on Nov. 26, 2025.
Brief Summary: To evaluate whether Desvenlafaxine can reduce the frequency and severity of TTH attacks in patients.
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Tension Type Headache
Intervention:
DRUG: Desvenlafaxine
Desvenlafaxine
DRUG: Placebo
Placebo
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Tongji Hospital
Information provided by (Responsible Party): Wensheng Qu, Tongji Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....